|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/48 |
| (11) | Number of the document | 2349341 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09748174.1 |
| Date of filing the European patent application | 2009-10-14 | |
| (97) | Date of publication of the European application | 2011-08-03 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/060633 |
| Date | 2009-10-14 |
| (87) | Number | WO 2010/045321 |
| Date | 2010-04-22 |
| (30) | Number | Date | Country code |
| 105548 P | 2008-10-15 | US |
| (72) |
MITTERER, Artur, AT
GRANINGER, Michael, AT
HASSLACHER, Meinhard, AT
|
| (73) |
Baxter Healthcare SA,
Thurgauerstrasse 130, 8152 Glattpark (Opfikon),
CH
Baxter International Inc, One Baxter Parkway, Deerfield, IL 60015, US |
| (54) | PEGYLATION OF RECOMBINANT BLOOD COAGULATION FACTORS IN THE PRESENCE OF BOUND ANTIBODIES |
| PEGYLATION OF RECOMBINANT BLOOD COAGULATION FACTORS IN THE PRESENCE OF BOUND ANTIBODIES |